Akebia Therapeutics, Inc.AKBANASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+15.5%
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

3Y CAGR
+15.5%/yr
vs +37.6%/yr prior
Acceleration
-22.1pp
Decelerating
Percentile
P100
Near historical high
vs 3Y Ago
1.5x
Solid growth
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202593.70%
2024-17.86%
202351.72%
202260.81%
202141.50%
2020-7.20%
2019-60.54%
201816.95%
201750.83%
2016-57.21%